| Code | Description | Claims | Beneficiaries | Total Paid |
| 99241 |
|
1,215 |
955 |
$119K |
| 99242 |
|
114 |
93 |
$17K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
563 |
359 |
$12K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
102 |
99 |
$11K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
362 |
268 |
$6K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
189 |
163 |
$4K |
| S9083 |
Global fee urgent care centers |
17 |
16 |
$3K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
418 |
314 |
$3K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
565 |
418 |
$1K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
212 |
157 |
$287.44 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
310 |
268 |
$128.59 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
100 |
72 |
$45.80 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
80 |
54 |
$15.70 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
73 |
52 |
$0.00 |